본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

韓藥業事의 說明義務

이용수 50

영문명
Oriental Medicine Retailer s Duty to Inform
발행기관
한국민사법학회
저자명
金載亨(Kim, Jae-Hyung)
간행물 정보
『민사법학』제26호, 241~276쪽, 전체 36쪽
주제분류
사회과학 > 사회과학일반
파일형태
PDF
발행일자
2004.09.30
7,120

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Occasionally unfortunate accidents do occur when they could have been easily prevented. A good example is the Supreme Court case decided December 10, 2002. The defendant in this case, was an oriental medicine retailer who sold a medicinal herb called Cho-Oh (Acontum jaluense Komarov) to one of the plaintiffs, a purchaser, but failed to inform the indications and dosage of the herb and other required information, and also failed to warn the purchaser of the risks associated with it. The purchaser prepared a home-brewed herbal medicine by boiling Cho-Oh in water, which was subsequently consumed by the purchaser s husband. Unfortunately, the husband died soon after and it turned out that the cause of his death was a fatal dose of the Cho-Oh concentrate. The victim s family, the wife and children, brought a claim against the retailer for damages. The Supreme Court held that the defendant was liable for the damages on the basis that he breached the Duty to Inform and the victim was consequently denied the right to make an informed choice(i.e the right to self- determination) on the herbal products to fit their medical needs. The Supreme Court s decision had the effect of imposing on the oriental medicine retailer the same Duty to Inform standard, which the courts have generally applied to medical doctors or pharmacists. Accordingly, the question arises as to whether it is fair to subject the oriental medicine retailers to such standard, given that the doctrine of duty to inform was developed with a view to protecting the patient s right to informed consent i.e. to make informed health care decision, in particular with respect to the medical treatments suggested by a doctor or a pharmacist. The Supreme Court is right in concluding that there is tort liability for this breach of duty of care in selling herbal medicine. However, the ruling still begs the question as to whether the oriental medicine retailer s failure to inform the purchaser could reasonably be considered as infringing the right of self-determination of the patient. Even if the retailer is shown to be highly knowledgeable of herbs and their medical uses, due consideration should be given to the fact that he is simply a merchant running a herb store. As such a distinction should be drawn between the Duty to Inform as is applicable to a doctor and to an oriental medicine retailer (a non-medical profession). Still there remains other grounds to impose on the oriental medicine retailer tort liability for his failure to inform the purchaser of the potential health risks associated with herbal medicines. The defendant retailer has the duty to warn the patient of risks and provide prescription instructions including the proper proportions of the herbal ingredients, and information, if any, on detoxification methods. This duty, however, is not to protect the patient s personal self-determination right. In this sense, the Oriental Medicine Retailer s duty to warn of possible side effects can be distinct from a doctor s Duty to Inform his patient of material risks and alternative treatments, which is designed to protect the patient s personal self-determination right. In principle, a doctor has the duty to inform the patient in person of the suggested course of treatment and other relevant and material information, barring any exceptional circumstances that render the patient unable to understand the information provided, for example, where the patient is unconscious. On the other hand, the Oriental Medicine Retailer is not necessarily obliged to provide the herb-related information directly to the actual medicine taker, since the Oriental Medicine Retailer s duty to inform is not performed with a view protecting a patient/medicine-taker s self-determination right. Nevertheless, the

목차

[事實關係 및 判決]
[硏 究]
Ⅰ. 問題의 提起
Ⅱ. 醫療行爲에서 說明義務에 관한 법리의 발전
Ⅲ. 醫師 또는 藥師의 說明義務를 韓藥業士에게도 인정할 수 있는지 여부
Ⅳ. 民事責任體系에서 韓藥業士의 說明義務의 위치 - 債務不履行責任과 不法行爲責任의 관계
Ⅴ. 韓藥業士의 說明義務 違反으로 인한 損害賠償의 範圍
Ⅵ. 結論

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

金載亨(Kim, Jae-Hyung). (2004).韓藥業事의 說明義務. 민사법학, (26), 241-276

MLA

金載亨(Kim, Jae-Hyung). "韓藥業事의 說明義務." 민사법학, .26(2004): 241-276

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제